Drug Markets/abacavir sulfate, dolutegravir sodium, lamivudine

abacavir sulfate, dolutegravir sodium, lamivudine

1 NDCs across 1 manufacturers|0 Generic,1 Brand

Total NDCs

0G / 1B

Manufacturers

competing in market

Price Spread

$130.00 – $130.00

7d Activity

1 flat

of 1 total NDCs

Monthly average NADAC price per unit, split by generic and brand

1 manufacturer producing abacavir sulfate, dolutegravir sodium, lamivudine

1 NDCs total, 1 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
TRIUMEQ 600-50-300 MG TABLET	49702023113	ViiV Healthcare Company	$130.0048 per EA	—	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor